These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 32654779)

  • 1. Botulinum toxin for benign essential blepharospasm: A systematic review and an algorithmic approach.
    Rayess YA; Awaida CJ; Jabbour SF; Ballan AS; Sleilati FH; Abou Zeid SM; Nasr MW
    Rev Neurol (Paris); 2021; 177(1-2):107-114. PubMed ID: 32654779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preseptal and Pretarsal Botulinum Toxin Injection in Hemifacial Spasm and Blepharospasm: A 10-Year Comparative Study.
    Teekaput C; Teekaput K; Thiankhaw K
    Ther Clin Risk Manag; 2023; 19():35-42. PubMed ID: 36660550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative crossover study on the treatment of hemifacial spasm and blepharospasm: preseptal and pretarsal botulinum toxin injection techniques.
    Lolekha P; Choolam A; Kulkantrakorn K
    Neurol Sci; 2017 Nov; 38(11):2031-2036. PubMed ID: 28884242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term efficacy and safety of botulinum toxin A injections to treat blepharospasm and hemifacial spasm.
    Ababneh OH; Cetinkaya A; Kulwin DR
    Clin Exp Ophthalmol; 2014 Apr; 42(3):254-61. PubMed ID: 23844601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome of Injection Botulinum Toxin in Blepharospasm.
    Amatya M; Limbu B; Sthapit PR; Gurung HB; Saiju R
    Nepal J Ophthalmol; 2021 Jan; 13(25):40-49. PubMed ID: 33981096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of the injection botulinum toxin A in cases of blepharospasm syndrome, hemifacial spasm and Meige's syndrome.
    Bastola P; Chaudhary M; Agrawal JP; Shah DN
    Kathmandu Univ Med J (KUMJ); 2010; 8(31):305-10. PubMed ID: 22610735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Botulinum toxin type A therapy for blepharospasm.
    Costa J; Espírito-Santo C; Borges A; Ferreira JJ; Coelho M; Moore P; Sampaio C
    Cochrane Database Syst Rev; 2005 Jan; (1):CD004900. PubMed ID: 15674969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of preseptal and pretarsal injections of botulinum toxin in the treatment of blepharospasm and hemifacial spasm.
    Cakmur R; Ozturk V; Uzunel F; Donmez B; Idiman F
    J Neurol; 2002 Jan; 249(1):64-8. PubMed ID: 11954870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. THE EFFECT OF BOTULINUM TOXIN TYPE A IN PATIENTS WITH ESSENTIAL BLEPHAROSPASM.
    Gaćina K; Lešin M; Sarajčev D; Rotim N
    Acta Clin Croat; 2022 Nov; 61(3):379-385. PubMed ID: 37492354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complications of Preseptal Versus Pretarsal Botulinum Toxin Injection in Benign Essential Blepharospasm: A Randomized Controlled Trial.
    Sanguandikul L; Apinyawasisuk S; Jariyakosol S; Hirunwiwatkul P; Chongpison Y
    Am J Ophthalmol; 2021 Dec; 232():9-16. PubMed ID: 33965414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pretarsal blepharospasm: Clinical and electromyographic characteristics.
    Grandas F; Traba A; Perez-Sanchez JR; Esteban A
    Clin Neurophysiol; 2020 Jul; 131(7):1678-1685. PubMed ID: 32280019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Botulinum toxin in the treatment of paralytic strabismus and essential blepharospasm.
    Thomas R; Mathai A; Rajeev B; Sen S; Jacob P
    Indian J Ophthalmol; 1993 Oct; 41(3):121-4. PubMed ID: 8125543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Botulinum Toxin for Eyebrow Shaping: A Systematic Review.
    Jabbour S; Awaida C; Kechichian E; Rayess Y; Abdelmassih Y; Noel W; Hachem LE; Nasr M
    Dermatol Surg; 2017 Dec; 43 Suppl 3():S252-S261. PubMed ID: 33065951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pretarsal application of botulinum toxin for treatment of blepharospasm.
    Aramideh M; Ongerboer de Visser BW; Brans JW; Koelman JH; Speelman JD
    J Neurol Neurosurg Psychiatry; 1995 Sep; 59(3):309-11. PubMed ID: 7673963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Innervation zone of orbicularis oculi muscle and implications for botulinum A toxin therapy.
    Borodic GE; Cozzolino D; Ferrante R; Wiegner AW; Young RR
    Ophthalmic Plast Reconstr Surg; 1991; 7(1):54-60. PubMed ID: 1708272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of botulinum toxin in benign essential Blepharospasm: Desirable & undesirable effects.
    Anwar MS; Zafar H
    Pak J Med Sci; 2013 Nov; 29(6):1389-93. PubMed ID: 24550960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disabling muscle of Riolan: A novel concept of orbicularis oculi myectomy for refractory benign essential blepharospasm.
    Takahashi Y; Vaidya A; Lee PAL; Kono S; Kakizaki H
    Eur J Ophthalmol; 2021 Nov; 31(6):3411-3417. PubMed ID: 33579161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myobloc for the treatment of benign essential blepharospasm in patients refractory to botox.
    Dutton JJ; White JJ; Richard MJ
    Ophthalmic Plast Reconstr Surg; 2006; 22(3):173-7. PubMed ID: 16714924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment selections of 239 patients with blepharospasm and Meige syndrome over 11 years.
    Mauriello JA; Dhillon S; Leone T; Pakeman B; Mostafavi R; Yepez MC
    Br J Ophthalmol; 1996 Dec; 80(12):1073-6. PubMed ID: 9059273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term follow-up of patients with frontalis sling operation in the treatment of essential blepharospasm unresponsive to botulinum toxin therapy.
    Wabbels B; Roggenkämper P
    Graefes Arch Clin Exp Ophthalmol; 2007 Jan; 245(1):45-50. PubMed ID: 16874524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.